About Atrium Health Addiction Services
Services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; Other contracted prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Cognitive behavioral therapy; Contingency management/motivational incentives; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private non-profit organization
License/Certification/Accreditation
State Substance use treatment agency; State mental health department; The Joint Commission
Payment/Insurance/Funding Accepted
Medicare; Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Outreach to persons in the community; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education
Recovery Support Services
Housing services; Mentoring/peer support
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Young Adults; Adults
Gender Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping not permitted
Ancillary Services
Case management service; Mental health services; Social skills development; Transportation assistance; Suicide prevention services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; Other contracted prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Cognitive behavioral therapy; Contingency management/motivational incentives; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private non-profit organization
License/Certification/Accreditation
State Substance use treatment agency; State mental health department; The Joint Commission
Payment/Insurance/Funding Accepted
Medicare; Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Outreach to persons in the community; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education
Recovery Support Services
Housing services; Mentoring/peer support
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Young Adults; Adults
Gender Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping not permitted
Ancillary Services
Case management service; Mental health services; Social skills development; Transportation assistance; Suicide prevention services
